腸内細菌科感染症(Enterobacteriaceae Infections):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016264)
◆英語タイトル:Enterobacteriaceae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016264
◆発行日:2021年01月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥208,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥416,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥624,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[腸内細菌科感染症(Enterobacteriaceae Infections):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、腸内細菌科感染症(Enterobacteriaceae Infections)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・腸内細菌科感染症(Enterobacteriaceae Infections):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・腸内細菌科感染症(Enterobacteriaceae Infections)のフェーズ3治験薬の状況
・腸内細菌科感染症(Enterobacteriaceae Infections)治療薬の市場規模(販売予測)
・腸内細菌科感染症(Enterobacteriaceae Infections)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・腸内細菌科感染症(Enterobacteriaceae Infections)のフェーズ3治験薬分析
・開発中止中の腸内細菌科感染症(Enterobacteriaceae Infections)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Enterobacteriaceae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Enterobacteriaceae Infections Report is to understand the market and pipeline status of the drugs around the Enterobacteriaceae Infections to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2021. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Enterobacteriaceae Infections. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Enterobacteriaceae Infections.
• A review of the marketed products under prescription for Enterobacteriaceae Infections, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Enterobacteriaceae Infections with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Enterobacteriaceae Infections drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Enterobacteriaceae Infections drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Enterobacteriaceae Infections drugs.
• Coverage of Enterobacteriaceae Infections Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2021.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2021
6. Marketed Drugs for Enterobacteriaceae Infections
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Enterobacteriaceae Infections
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Enterobacteriaceae Infections
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Enterobacteriaceae Infections Therapeutic Market, US, Marketed Drugs by Application Type, 2019
• Enterobacteriaceae Infections Therapeutic Market, US, Marketed Drugs by Marketing Status, 2019
• Enterobacteriaceae Infections Therapeutic Market, US, (Year), 2019
• Enterobacteriaceae Infections Marketed Drugs, API Manufacturers by US DMF Status, 2019
• Enterobacteriaceae Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, Europe by Country, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, India by State, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, China by Province, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers by Geography 2019
• Enterobacteriaceae Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Enterobacteriaceae Infections Therapeutic Market, Global Sales-2021 (in million USD)
• API Manufacturers for Drug, 2019
• Phase III Drugs for Enterobacteriaceae Infections, 2019
• Discontinued Drugs for Enterobacteriaceae Infections, 2019


List of Figures
• Enterobacteriaceae Infections Therapeutic Market, US, Marketed Drugs by Application Type (%), 2019
• Enterobacteriaceae Infections Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2019
• Enterobacteriaceae Infections Therapeutic Market, US, (Year), 2019
• Enterobacteriaceae Infections Marketed Drugs, API Manufacturers by US DMF Status (%), 2019
• Enterobacteriaceae Infections Marketed Drugs, US DMF Status Drug Specific (Number), 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, Europe by Country, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, India by State, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers, China by Province, 2019
• Enterobacteriaceae Infections Drugs, API Manufacturers by Geography 2019
• Enterobacteriaceae Infections Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2019
• Enterobacteriaceae Infections Therapeutic Market, Global Sales 2021 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2019


*** レポートのキーワード ***

腸内細菌科感染症(Enterobacteriaceae Infections)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国のミクロブタニル市場2017
    The 'Global and Chinese Myclobutanil Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Myclobutanil industry with a focus on the Chinese market. The report provides key statistics on the market status of the Myclobutanil manufacturers …
  • 高度創傷治療デバイスの世界市場
    Virtual networking is a technology that streamlines the control of remotely located devices or server through the Internet. It enables users to communicate locally and remotely, across similar and dissimilar networks, through a simplified interface. This technology combines hardware and software net …
  • 世界のマイクロ潅漑システム市場
    KEY FINDINGSThe Global Micro Irrigation Systems market is expected to grow at 18.26% CAGR during the forecast period of 2018-2026. Factors such as the growing interest of farmers to use micro-irrigation systems, decreasing per capita arable land and growing demand of MIS from emerging economies are …
  • 給餌システムの世界市場
    Feeding Systems market worldwide is projected to grow by US$672. 9 Million, driven by a compounded growth of 7.9%. Hardware, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.6%. The shifting dynamics supporting this growth makes it critical for businesse …
  • ソリッドステートドライブ(SSD)の世界市場
    The Global Solid State Drive (SSD) Market size is expected to reach $18.4 billion by 2023, rising at a market growth of 14.1% CAGR during the forecast period. A solid-state drive (SSD) is a nonvolatile storage device which is used to store persistent data on solid-state flash memory. Solid-state dri …
  • バイオテクノロジー試薬の世界市場2020-2024
    Global Biotechnology Reagents Market 2020-2024 Technavio has been monitoring the biotechnology reagents market and it is poised to grow by $ 37.87 bn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on biotechnology reagents market provides a holistic analysis, ma …
  • ココアパウダーの世界市場予測・動向・競合分析
    Increasing production of chocolate confections and syrup is expected to derive demand for cocoa powder globally. As consumption of cocoa powder benefits the cardiovascular health of the consumers, which is expected to rev up sales of cocoa powder significantly. This report, published by Fact.MR, pro …
  • UAEの個人衛生用品市場:消費者およびマーケットインサイト
    Summary The UAE is a high income country with the majority of Emiratis enjoying a high standard of living and affluent Emiratis are seeking high-quality and premium Personal Hygiene products. The Personal Hygiene market in the UAE is forecast to register higher growth in value and volume terms durin …
  • 樹脂添加剤の世界市場:販売動向2017
    Notes:Sales, means the sales volume of Resin Additives Revenue, means the sales value of Resin Additives This report studies sales (consumption) of Resin Additives in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, p …
  • 心臓血管モニタリングおよび診断装置の世界市場:産業分析、市場規模、市場シェア、成長、動向、予測
    This report on the cardiovascular monitoring and diagnostic devices market analyzes the current and future scenario of the global market. Stroke, heart failure, and other prominent cardiovascular diseases are increasing the usage of cardiovascular monitoring and diagnostic devices. Rising geriatric …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016264 )"腸内細菌科感染症(Enterobacteriaceae Infections):治療薬市場2019(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Enterobacteriaceae Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。